-
140 jobs in jeopardy as Recipharm weighs the fate of money-losing plant
fiercepharma
December 20, 2018
A Recipharm plant in the U.K. has been on the edge financially for some time, having been unprofitable for three years. Now, the Swedish-based CDMO says the cost of fixing issues raised by U.K. authorities may be the breaking point.
-
Rentschler Biopharma to Purchase U.S. Manufacturing Site from Shire
americanpharmaceuticalreview
December 18, 2018
Rentschler Biopharma announced the company has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA......
-
Lonza to establish new base in China using GE healthcare solution
biospectrumasia
December 17, 2018
New biologics facility, scheduled to be operational in 2020, will provide development and manufacturing facilities from early- to late-clinical and early-commercial stages.
-
Lonza to Establish Bio Mfg. Base in China
contractpharma
December 12, 2018
Lonza?entered an agreement with?GE Healthcareunder which GE will deliver a biologics facility to Lonza in Guangzhou. The facility is part of a larger biomanufacturing initiative between GE Healthcare
-
Niche CDMO confirms spray drying for highly potent drugs
cphi-online
November 15, 2018
Idifarma's GMP spray drying technology for highly potent drugs up to Category 4 OEL/OEB is now operational.
-
Particle Sciences to open new commercial facility
cphi-online
November 14, 2018
Particle Sciences, a Lubrizol LifeSciences company and US-based pharmaceutical CDMO, is opening a new commercial drug product manufacturing facility at the end of Q4 2018.
-
Recro Pharma expands CDMO business in Georgia
fiercepharma
November 08, 2018
Recro Pharma was granted a March 2019 PDUFA date for its non-opioid pain drug after providing the FDA with additional data and answering manufacturing questions raised in a complete response letter.
-
Generics, small molecule injectables to drive growth, says Piramal
biospectrumasia
October 23, 2018
Small molecule injectables are likely to expand at a faster rate'Singapore:India's Piramal Enterprises' Phar
-
ADC Market to Grow to $4B
contractpharma
October 10, 2018
A new analysis in the CPhI Annual Report estimates the increase in growth by 2023
-
Vetter Grants Award for Novel Idea at Injection 2.0
biospectrumasia
September 29, 2018
On September 25, the four groups presented their ideas in short presentations at the company’s Ravensburg Vetter West site
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
